1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Hypoxic-Ischemic Encephalopathy Global Clinical Trials Review, H2, 2014

Hypoxic-Ischemic Encephalopathy Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Hypoxic-Ischemic Encephalopathy Global Clinical Trials Review, H2, 2014" provides data on the Hypoxic-Ischemic Encephalopathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hypoxic-Ischemic Encephalopathy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hypoxic-Ischemic Encephalopathy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Hypoxic-Ischemic Encephalopathy Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Hypoxic-Ischemic Encephalopathy 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Hypoxic-Ischemic Encephalopathy to Central Nervous System Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Hypoxic-Ischemic Encephalopathy to Central Nervous System Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials in E7 Countries by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Unaccomplished Trials of Hypoxic-Ischemic Encephalopathy 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Prominent Drugs 27
Clinical Trial Overview of Top Institutes / Government 28
Eunice Kennedy Shriver National Institute of Child Health and Human Development 28
Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 28
University of California, San Francisco 29
Clinical Trial Overview of University of California, San Francisco 29
Vanderbilt University 30
Clinical Trial Overview of Vanderbilt University 30
University of Tanta 31
Clinical Trial Overview of University of Tanta 31
Children's Hospital of Fudan University 32
Clinical Trial Overview of Children's Hospital of Fudan University 32
Imperial College London 33
Clinical Trial Overview of Imperial College London 33
McGill University Health Center 34
Clinical Trial Overview of McGill University Health Center 34
University Hospital Freiburg 35
Clinical Trial Overview of University Hospital Freiburg 35
Duke University 36
Clinical Trial Overview of Duke University 36
Washington University School of Medicine 37
Clinical Trial Overview of Washington University School of Medicine 37
Five Key Clinical Profiles 38
Appendix 56
Abbreviations 56
Definitions 56
Research Methodology 57
Secondary Research 57
About GlobalData 58
Contact Us 58
Disclaimer 58
Source 58

List of Tables
Hypoxic-Ischemic Encephalopathy Therapeutics, Global, Clinical Trials by Region, 2014* 6
Hypoxic-Ischemic Encephalopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Hypoxic-Ischemic Encephalopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Hypoxic-Ischemic Encephalopathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 9
Hypoxic-Ischemic Encephalopathy Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Hypoxic-Ischemic Encephalopathy Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Hypoxic-Ischemic Encephalopathy Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 12
Proportion of Hypoxic-Ischemic Encephalopathy to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 13
Hypoxic-Ischemic Encephalopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Hypoxic-Ischemic Encephalopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Hypoxic-Ischemic Encephalopathy to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 16
Hypoxic-Ischemic Encephalopathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Hypoxic-Ischemic Encephalopathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18
Hypoxic-Ischemic Encephalopathy Therapeutics, Global, Clinical Trials by Phase, 2014* 19
Hypoxic-Ischemic Encephalopathy Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 20
Hypoxic-Ischemic Encephalopathy Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Hypoxic-Ischemic Encephalopathy Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Hypoxic-Ischemic Encephalopathy Therapeutics, Global, Terminated Clinical Trials, 2014* 23
Hypoxic-Ischemic Encephalopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Hypoxic-Ischemic Encephalopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 25
Hypoxic-Ischemic Encephalopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 26
Hypoxic-Ischemic Encephalopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
Hypoxic-Ischemic Encephalopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2014* 28
Hypoxic-Ischemic Encephalopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014* 29
Hypoxic-Ischemic Encephalopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2014* 30
Hypoxic-Ischemic Encephalopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Tanta, 2014* 31
Hypoxic-Ischemic Encephalopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Hospital of Fudan University, 2014* 32
Hypoxic-Ischemic Encephalopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2014* 33
Hypoxic-Ischemic Encephalopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by McGill University Health Center, 2014* 34
Hypoxic-Ischemic Encephalopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Freiburg, 2014* 35
Hypoxic-Ischemic Encephalopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2014* 36
Hypoxic-Ischemic Encephalopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2014* 37

List of Figures
Hypoxic-Ischemic Encephalopathy Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Hypoxic-Ischemic Encephalopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Hypoxic-Ischemic Encephalopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Hypoxic-Ischemic Encephalopathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 9
Hypoxic-Ischemic Encephalopathy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Hypoxic-Ischemic Encephalopathy Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Hypoxic-Ischemic Encephalopathy Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 12
Proportion of Hypoxic-Ischemic Encephalopathy to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 13
Hypoxic-Ischemic Encephalopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Hypoxic-Ischemic Encephalopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Hypoxic-Ischemic Encephalopathy to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 16
Hypoxic-Ischemic Encephalopathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Hypoxic-Ischemic Encephalopathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18
Hypoxic-Ischemic Encephalopathy Therapeutics, Global, Clinical Trials by Phase (%), 2014* 19
Hypoxic-Ischemic Encephalopathy Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 20
Hypoxic-Ischemic Encephalopathy Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Hypoxic-Ischemic Encephalopathy Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Hypoxic-Ischemic Encephalopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Hypoxic-Ischemic Encephalopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 25
Hypoxic-Ischemic Encephalopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
GlobalData Methodology 57

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.